广州洁特生物过滤股份有限公司2025年第一季度业绩预告的自愿性披露公告

Group 1 - The company forecasts a revenue of 123 million yuan for Q1 2025, representing an increase of 24.72 million yuan or 25.16% compared to the same period last year [3][5] - The net profit attributable to the parent company is expected to be 14 million yuan, an increase of 5.82 million yuan or 71.18% year-on-year [3][5] - The net profit attributable to the parent company after deducting non-recurring gains and losses is projected to be 13.5 million yuan, reflecting an increase of 9.26 million yuan or 218.52% compared to the previous year [3][5] Group 2 - The company attributes the performance improvement to its strengths in R&D innovation, production processes, and refined management, focusing on market demands and enhancing product competitiveness [6] - The life sciences product business continues to grow, with an increasing market share, while the company is also pushing for internal cost reduction and efficiency improvements [6]